MOSAIQ Oncology Information System with Particle Therapy License (License Kit 45700000000IQRO)

FDA Recall #Z-1078-2026 — Class II — December 10, 2025

Recall #Z-1078-2026 Date: December 10, 2025 Classification: Class II Status: Ongoing

Product Description

MOSAIQ Oncology Information System with Particle Therapy License (License Kit 45700000000IQRO)

Reason for Recall

Using oncology information system that manages workflow may result in overtreatment if:Plan delivered with Particle Therapy IHE-RO TDW-II interface,With one field per fraction or last field partial treatment,Partial treatment occurs followed by treatment field interruptions with manually recorded partial treatment,Then treatment unit doesn't check meterset value so partial treatment delivered twice

Recalling Firm

Elekta, Inc. — Atlanta, GA

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Devices

Product Quantity

1

Distribution

US Nationwide distribution in the state of TX.

Code Information

MOSAIQ v 3.10.200, and 3.1.1.0 up to and including v 3.2.3.1 with Particle Base. Software Versions: 3.10.200, 3.1.1.0, 3.1.2.0, 3.1.3.0, 3.1.3.1, 3.1.3.2, 3.1.3.3, 3.1.3.4, 3.2.0.0, 3.2.1.0, 3.2.1.1, 3.2.1.2, 3.2.1.3, 3.2.1.4, 3.2.2.0, 3.2.2.1, 3.2.3.0, 3.2.3.1 UDI-DI: 07340201500026, 07340201500071

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated